Fri, March 17, 2023
Thu, March 16, 2023
Wed, March 15, 2023
Tue, March 14, 2023
Mon, March 13, 2023
Fri, March 10, 2023
Thu, March 9, 2023

Chris Shibutani Maintained (AMLX) at Hold with Increased Target to $47 on, Mar 14th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-47-on-mar-14th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Chris Shibutani of Goldman Sachs, Maintained "Amylyx Pharmaceuticals, Inc." (AMLX) at Hold with Increased Target from $41 to $47 on, Mar 14th, 2023.

Chris has made no other calls on AMLX in the last 4 months.



There is 1 other peer that has a rating on AMLX. Out of the 1 peers that are also analyzing AMLX, 0 agree with Chris's Rating of Hold.



This is the rating of the analyst that currently disagrees with Chris


  • Geoff Meacham of "B of A Securities" Initiated at Strong Buy and Held Target at $50 on, Thursday, January 5th, 2023

Publication Contributing Sources